Skip to main content

Table 2 Relation between clinicopathologic characteristics and ARMCX1 expression in LUAD

From: ARMCX1 inhibits lung adenocarcinoma progression by recruiting FBXW7 for c-Myc degradation

Factors

 

n

ARMCX1 expression

X2

P value

Low

High

Age(y)

< 50

10

7

3

0.014

0.905

≥ 50

78

56

22

Gender

Male

52

37

15

0.011

0.913

Female

36

26

10

Clinical stage*

I-II

48

29

19

8.874

0.002

III-IV

27

25

2

T stage*

T1-T2

65

43

22

4.292

0.038

T3-T4

20

18

2

N stage*

N0-N1

55

36

19

4.383

0.036

N2-N3

20

18

2

  1. *Some patients are not included in the statistics owing to the missing data